Published March 2026 · White Market Peptides Research Library
Overview
GLOW is a research-grade peptide blend combining three individually well-characterized compounds — GHK-Cu (10 mg), BPC-157 (10 mg), and TB-500 (50 mg) — in a single 70 mg lyophilized preparation. This three-component blend brings together peptides with distinct molecular mechanisms: copper-mediated gene expression modulation (GHK-Cu), nitric oxide system cytoprotection (BPC-157), and actin-dependent cell migration (TB-500).
Each component peptide has an independent body of published preclinical research. GHK-Cu has been studied since its isolation from human plasma in 1973, with over four decades of research into its effects on gene expression and extracellular matrix biology. BPC-157 has been investigated in over 100 preclinical studies examining cytoprotection and vascular biology. TB-500, the active fragment of Thymosin Beta-4, has been studied for its roles in actin dynamics, cell migration, and angiogenesis since the 1970s.
The GLOW blend provides researchers with a multi-pathway research tool engaging copper-dependent transcriptomic regulation, NO-mediated vascular biology, and cytoskeletal dynamics simultaneously.
Molecular Profile
| Blend Composition | GHK-Cu (10 mg) + BPC-157 (10 mg) + TB-500 (50 mg) |
| Total Weight | 70 mg per vial |
| Format | Lyophilized powder |
GHK-Cu
| CAS Number | 49557-75-7 |
| Formula | C14H24CuN6O4 |
| Molecular Weight | 403.93 g/mol |
BPC-157
| CAS Number | 137525-51-0 |
| Formula | C62H98N16O22 |
| Molecular Weight | 1419.5 g/mol |
TB-500
| CAS Number | 885340-08-9 |
| Formula | C38H68N10O14 |
| Molecular Weight | 889.01 g/mol |
Research Rationale for Combination
The GLOW blend combines three peptides that influence tissue biology through fundamentally different mechanisms. GHK-Cu delivers bioavailable copper and modulates the expression of thousands of human genes involved in ECM remodeling and antioxidant defense. BPC-157 engages the NO system and promotes vascular recruitment through cytoprotective pathways. TB-500 maintains actin monomer reserves and promotes cell migration through cytoskeletal dynamics. This combination engages transcriptomic, vascular, and structural cellular pathways simultaneously.
The inclusion of TB-500 as the predominant component (50 mg of 70 mg total) reflects its established role as the primary G-actin sequestering peptide and the relatively higher concentrations used in published preclinical cell migration studies.
Component Research Summaries
GHK-Cu: Gene Expression and ECM Remodeling
Discovered by Loren Pickart in 1973, GHK-Cu modulates the expression of over 4,000 human genes at micromolar concentrations, including genes involved in collagen synthesis, MMP/TIMP balance, and antioxidant defense. The copper ion serves as a cofactor for lysyl oxidase, superoxide dismutase, and other copper-dependent enzymes critical for tissue integrity. For comprehensive details, see our GHK-Cu Research Overview.
BPC-157: Cytoprotection and Vascular Biology
BPC-157 modulates the nitric oxide system and promotes cytoprotection across multiple organ systems in preclinical models. Studies have demonstrated vascular recruitment, endothelial protection, and angiogenic effects. The peptide maintains stability in gastric juice and has been investigated in Phase II IBD trials. For comprehensive details, see our BPC-157 Research Overview.
TB-500: Actin Dynamics and Cell Migration
TB-500 sequesters G-actin monomers, maintaining cellular reserves for rapid cytoskeletal reorganization. Preclinical studies have demonstrated keratinocyte migration enhancement at picomolar concentrations, endothelial tube formation through the actin-binding domain, and cardiovascular effects in porcine experimental models. For comprehensive details, see our TB-500 Research Overview.
Key Areas of Combined Investigation Interest
Multi-Pathway Tissue Biology
The three-component blend engages gene expression (GHK-Cu), vascular (BPC-157), and structural/migratory (TB-500) pathways. This multi-pathway engagement provides researchers with a tool for studying how transcriptomic, vascular, and cytoskeletal processes interact in tissue models.
Convergent Angiogenic Signaling
All three components have independently demonstrated angiogenic effects in preclinical models through distinct mechanisms. GHK-Cu modulates angiogenesis-related gene expression, BPC-157 promotes vascular recruitment through NO-dependent pathways, and TB-500 stimulates endothelial differentiation through its actin-binding domain.
ECM Remodeling and Matrix Biology
GHK-Cu’s established effects on collagen synthesis, MMP/TIMP regulation, and glycosaminoglycan production are complemented by TB-500’s influence on cell migration within the extracellular matrix and BPC-157’s protective effects on tissue architecture.
Key Published References (Component Peptides)
- Pickart L, et al. “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.” Biomed Res Int. 2015;2015:648108. PMC: 4508379.
- Pickart L, et al. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” Int J Mol Sci. 2018;19(7):1987. PMC: 6073405.
- Sikiric P, et al. “Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection.” Curr Pharm Des. 2020;26(1):25–40. PMID: 31158953.
- Goldstein AL, et al. “Thymosin β4: Actin-Sequestering Protein Moonlights to Repair Injured Tissues.” Trends Mol Med. 2005;11(9):421–429. PMID: 16099219.
- Philp D, et al. “Thymosin Beta 4 Promotes Angiogenesis, Wound Healing, and Hair Follicle Development.” Mech Ageing Dev. 2004;125(2):113–115. PMID: 15037012.
Product Availability
This compound is available for research purchase: GLOW (70 mg)
Research Use Only. This product is sold exclusively for laboratory research use. It is not intended for human or animal consumption, clinical use, or veterinary applications, and is not intended to diagnose, treat, cure, or prevent any disease. All information presented here is a summary of published preclinical research and is provided for educational purposes only.
Available for Research
GLOW (70 mg)
99%+ purity · COA included · USA shipping